1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Infections, Respiratory in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantu, J; Geyer, R; Jett, M; Jo, SC; Mani, S; Moss, OR; Peacock, AD; Saxton, AM; White, DC | 1 |
Metcalfe, DD; Raphael, GD | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Respiratory
Article | Year |
---|---|
Mediators of airway inflammation.
Topics: Arachidonic Acids; Free Radicals; Histamine Release; Humans; Immunity, Cellular; Inflammation; Mast Cells; Membrane Lipids; Models, Biological; Platelet Activating Factor; Prostaglandins; Respiratory Tract Infections | 1986 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Respiratory
Article | Year |
---|---|
Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology.
Topics: Actinobacillus pleuropneumoniae; Animals; Breath Tests; Cell Line; Chromatography, High Pressure Liquid; Eicosanoids; Enterotoxins; Gas Chromatography-Mass Spectrometry; Humans; Lipids; Lipopolysaccharides; Lung Diseases; Phospholipids; Platelet Activating Factor; Rats; Respiratory Tract Infections; Spectrometry, Mass, Electrospray Ionization; Sus scrofa | 2005 |